KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 159 filers reported holding KITE PHARMA INC in Q2 2015. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,585,000 | -20.0% | 146,855 | -0.3% | 0.01% | -20.0% |
| Q3 2016 | $8,229,000 | +12.6% | 147,320 | +0.7% | 0.01% | +11.1% |
| Q2 2016 | $7,311,000 | +41.9% | 146,226 | +30.3% | 0.01% | +28.6% |
| Q1 2016 | $5,153,000 | -13.6% | 112,234 | +16.0% | 0.01% | -12.5% |
| Q4 2015 | $5,961,000 | +11.4% | 96,738 | +0.6% | 0.01% | +14.3% |
| Q3 2015 | $5,352,000 | -10.1% | 96,118 | -1.6% | 0.01% | 0.0% |
| Q2 2015 | $5,953,000 | +291.9% | 97,633 | +270.6% | 0.01% | +250.0% |
| Q1 2015 | $1,519,000 | -11.0% | 26,343 | -10.9% | 0.00% | 0.0% |
| Q4 2014 | $1,706,000 | +156.2% | 29,574 | +26.6% | 0.00% | +100.0% |
| Q3 2014 | $666,000 | – | 23,365 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $108,260,000 | 37.66% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,479,000 | 8.02% |
| RTW INVESTMENTS, LP | 343,503 | $15,770,000 | 5.72% |
| DSAM Partners (London) Ltd | 256,550 | $11,778,000 | 5.26% |
| Silver Rock Financial LLC | 109,199 | $5,013,000 | 5.09% |
| Casdin Capital, LLC | 75,000 | $3,443,000 | 3.95% |
| EcoR1 Capital, LLC | 150,000 | $6,887,000 | 2.41% |
| Vivo Capital, LLC | 193,193 | $8,869,000 | 2.22% |
| BB BIOTECH AG | 750,000 | $34,433,000 | 1.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 494,988 | $22,725,000 | 1.36% |